Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Staffurth

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|May 1, 2007
Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysisPatricia Harnden, Mike D Shelley, Bernadette Coles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2019
Impact of deviations in target volume delineation - Time for a new RTQA approach?Samantha Cox, Anne Cleves, Enrico Clementel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 10, 2005
Dose to bone marrow using IMRT techniques in prostate cancer patientsEduard Gershkevitsh, Catharine H Clark, John Staffurth, et al.
The Cochrane Database of Systematic Reviews|October 21, 2006
Chemotherapy for hormone-refractory prostate cancerMike Shelley, Craig Harrison, Bernadette Coles, et al.
Radiation Oncology (London, England)|November 17, 2017
Quality assurance of the SCOPE 1 trial in oesophageal radiotherapyLucy Wills, Rhydian Maggs, Geraint Lewis, et al.
Radiation Oncology (London, England)|February 8, 2016
The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trialRhys Carrington, Emiliano Spezi, Sarah Gwynne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2010
Resistance of CD45RA- T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancerZsuzsanna Tabi, Lisa K Spary, Sharon Coleman, et al.
Cancers|February 25, 2023
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B StudyRagu Ratnakumaran, Victoria Hinder, Douglas Brand, et al.
EJNMMI Research|April 13, 2018
Evaluation of prognostic models developed using standardised image features from different PET automated segmentation methodsCraig Parkinson, Kieran Foley, Philip Whybra, et al.
Journal of Translational Medicine|January 14, 2009
Can urinary exosomes act as treatment response markers in prostate cancer?Paul J Mitchell, Joanne Welton, John Staffurth, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|May 1, 2007
Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysisPatricia Harnden, Mike D Shelley, Bernadette Coles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2019
Impact of deviations in target volume delineation - Time for a new RTQA approach?Samantha Cox, Anne Cleves, Enrico Clementel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 10, 2005
Dose to bone marrow using IMRT techniques in prostate cancer patientsEduard Gershkevitsh, Catharine H Clark, John Staffurth, et al.
The Cochrane Database of Systematic Reviews|October 21, 2006
Chemotherapy for hormone-refractory prostate cancerMike Shelley, Craig Harrison, Bernadette Coles, et al.
Radiation Oncology (London, England)|November 17, 2017
Quality assurance of the SCOPE 1 trial in oesophageal radiotherapyLucy Wills, Rhydian Maggs, Geraint Lewis, et al.
Radiation Oncology (London, England)|February 8, 2016
The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trialRhys Carrington, Emiliano Spezi, Sarah Gwynne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2010
Resistance of CD45RA- T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancerZsuzsanna Tabi, Lisa K Spary, Sharon Coleman, et al.
Cancers|February 25, 2023
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B StudyRagu Ratnakumaran, Victoria Hinder, Douglas Brand, et al.
EJNMMI Research|April 13, 2018
Evaluation of prognostic models developed using standardised image features from different PET automated segmentation methodsCraig Parkinson, Kieran Foley, Philip Whybra, et al.
Journal of Translational Medicine|January 14, 2009
Can urinary exosomes act as treatment response markers in prostate cancer?Paul J Mitchell, Joanne Welton, John Staffurth, et al.
Pageof 9